(Q35648260)

9 August 2017

1 reference

title

Serologic correlates of protection for evaluating the response to meningococcal vaccines (English)

1 reference

9 August 2017

meningococcal vaccine

1 reference

2

Ray Borrow

1 reference

9 August 2017

Paul Balmer

1

1 reference

9 August 2017

1 February 2004

1 reference

Expert Review of Vaccines

9 August 2017

1 reference

9 August 2017

3

1 reference

9 August 2017

1

1 reference

9 August 2017

77-87

1 reference

Ability of 3 different meningococcal C conjugate vaccines to induce immunologic memory after a single dose in UK toddlers.

9 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.1.77

Protective efficacy of a serogroup B meningococcal vaccine in Sao Paulo, Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.1.77

NadA, a novel vaccine candidate of Neisseria meningitidis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.1.77

Serological basis for use of meningococcal serogroup C conjugate vaccines in the United Kingdom: reevaluation of correlates of protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.1.77

Antibody avidity as a surrogate marker of successful priming by Haemophilus influenzae type b conjugate vaccines following infant immunization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.1.77

Meningococcal serogroup a avidity indices as a surrogate marker of priming for the induction of immunologic memory after vaccination with a meningococcal A/C conjugate vaccine in infants in the United Kingdom.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.1.77

Clinical Efficacy of Meningococcus Group A Capsular Polysaccharide Vaccine in Children Three Months to Five Years of Age

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.1.77

Immune response to revaccination with meningococcal A and C polysaccharides in Gambian children following repeated immunisation during early childhood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.1.77

Induction of immunologic memory in Gambian children by vaccination in infancy with a group A plus group C meningococcal polysaccharide-protein conjugate vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.1.77

Reduced antibody response to revaccination with meningococcal serogroup A polysaccharide vaccine in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.1.77

Immunologic hyporesponsiveness to serogroup C but not serogroup A following repeated meningococcal A/C polysaccharide vaccination in Saudi Arabia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.1.77

Avidity maturation following vaccination with a meningococcal recombinant hexavalent PorA OMV vaccine in UK infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.1.77

Assessment of immune response to meningococcal disease: comparison of a whole-blood assay and the serum bactericidal assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.1.77

Age dependence of in vitro survival of meningococci in whole blood during childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.1.77

Comparison of functional immune responses in humans after intranasal and intramuscular immunisations with outer membrane vesicle vaccines against group B meningococcal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.1.77

Highly conserved Neisseria meningitidis surface protein confers protection against experimental infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.1.77

Neisseria lactamica protects against experimental meningococcal infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.1.77

Safety and immunogenicity of three lots of meningococcal serogroup C conjugate vaccine administered at 2, 3 and 4 months of age

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.1.77

Seroprevalence of meningococcal serogroup C bactericidal antibody in England and Wales in the pre-vaccination era

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.1.77

21 January 2018

Identifiers

DOI

10.1586/14760584.3.1.77

1 reference

9 August 2017

1 reference

PubMed ID

14761245